Dr. Armin W. Mäder, Chairman of the Board of directors & Co-Founder
Dr. Armin Mäder held senior positions in biotech and medtech companies such as Institut Straumann AG. He was the CFO/COO of the biotech start-up company AC Immune SA in Lausanne, Switzerland. Armin Mäder started his professional career in the UBS Investment Bank where he has worked in business development, business management and has delivered several time critical multi-million projects and business initiatives.
Armin Mäder holds an M.B.A. with a focus in finance from IMD in Lausanne. He graduated from the ETH Zurich with a Master’s degree in Natural Sciences and holds a PhD in Molecular Biology and Biophysics from ETH Zurich.
Dr. Hans Christoph Tanner, Board Member
Dr. Tanner has been a board member of Cosmo Pharmaceuticals S.p.A. since 2006, Since 2006 he has been Chief Financial Officer of Cosmo Pharmaceuticals S.p.A..
He is also a board member and head of the audit committee of DKSH AG (SIX:DKSH), board member and head of compensation committee of Private Equity Holding AG (SIX:PEH), board member of Qvanteq AG, Zurich, Beirat of Joimax GmbH, Karlsruhe.
From 2001 he worked as a corporate finance advisor and participated in numerous fund raisings, among others for the private placements of Cosmo Holding S.p.A. and of CureVac GmbH. He advised on the first successful unsolicited bid for a listed company in Switzerland.
From 1998 to 2001 he was a partner of Dr. Ernst Müller-Möhl, co-founded the 20 Minutes group of newspapers and founded A&A Active Investor, a listed investment company.
From 1992 to 1998 he was head of corporate finance of UBS in Zurich.
Dr. Tanner holds an economics diploma and a PhD in economics from the University of St. Gallen.
Dr. Suk-Woo Ha, Board Member
Dr. Suk-Woo Ha is CEO of Cellpack AG – Packaging. Before, he was Member of the Management Board and Sales & Marketing Director of the IVF HARTMANN AG, Neuhausen and the CEO of FUNNY Hygiene AG, Neuhausen & Kistler AG, Goldach, Subsidiaries of the IVF HARTMANN GROUP. Prior to that Suk-Woo Ha was Global Manager, Research & Development at JOMED AG in Beringen, Switzerland and Department Head, Research & Development at Boston Scientific, Schneider Technology Center in Bülach, Switzerland.
Dr. Suk-Woo Ha holds a Masters Degree in Materials Science from the ETH Zürich and a PhD from the ETH Zürich. He is an EMBA graduate from the University of St. Gallen (HSG).
Arik Zucker, Chief Executive Officer & Founder
Arik Zucker pursued a successful international job career within global medtech companies covering all aspects from product development to product management, including worldwide market introductions, as well as product life cycle management, etc. Arik Zucker has also worked in strategic business consulting at The Boston Consulting Group.
Arik Zucker graduated from the ETH Zurich with a Master’s degree in Physics.